StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Pfizer (PFE) Examining Ways to Save Allergan (AGN) Deal - Bloomberg
April 5, 2016 1:48 PM
(Updated - April 5, 2016 1:58 PM EDT)
Pfizer (NYSE: PFE) is scrambling to save its merger with Allergan ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Litigation
Mergers and Acquisitions
Rumors
Trader Talk
Next Articles
BMO Capital Reiterates Outperform on Pfizer (PFE) Following Allergan Merger Termination
April 6, 2016 10:42 AM
Leerink Partners Cuts Price Target on Allergan (AGN) Following New U.S. Treasury Regulations
April 6, 2016 7:13 AM
Allergen's (AGN) Stand-Alone Price Target is $282 at Deutsche Bank
April 5, 2016 3:45 PM
Pfizer (PFE) leaning toward abandoning deal with Allergan (AGN) - Reuters
April 5, 2016 1:41 PM